How many employees work at Chimpharm?
Chimpharm JSC has approximately 536 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Chimpharm’s total headcount has grown 19.9% from 447 employees in 2023 to 536 in 2026.
Is Chimpharm hiring right now?
Yes, Chimpharm is actively hiring. Chimpharm had 8 active job postings in 2026, a 13.3% increase from 2025 — see job openings & hiring trends.
About Chimpharm’s Workforce
Chimpharm JSC is a Pharmaceuticals company that employs 536 people worldwide as of March 2026. It is the 9th-largest by headcount among its peers. Founded in 1882, the company is headquartered in Kazakhstan.
Chimpharm's workforce has grown 19.9% from 2023 to 2026, up 1.6% year over year in 2026. It fell to a low of 446 in 2023 Q3 before recovering. Its workforce is concentrated most in Central and Western Asia (99.0%), followed by Southern Europe (1.0%).
Chimpharm's functional groups are Finance and Operations (50.8%), Engineering (33.4%), and Sales and Marketing (15.8%). The average salary is $21,680, highest in Central and Western Asia at a median of $13,000, up 2.2% year over year in 2026.
Chimpharm's active job postings rose 13.3% in 2026 to 8, with new postings per month climbing from 2 in 2023 to 4 in 2026. Overall employee sentiment is negative and broadly stable.
Sourced from Revelio Labs workforce data.
- Headquarters
- Kazakhstan
- Founded
- 1882
- Industry
- Pharmaceuticals
- Employees
- 536
- YoY
- +1.6% (+30)
As of March 2026
Chimpharm workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Chimpharm. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsChimpharm Annual Employee Count (2023-2026)
- Chimpharm had 536 employees in 2026, a 1.6% increase (+30) from 2025.
- Chimpharm had 533 employees in 2025, a 2.9% increase (+29) from 2024.
- Chimpharm had 504 employees in 2024, a 5.7% increase (+32) from 2023.
- Chimpharm had 472 employees in 2023, a 2.4% increase (+37) from 2022.
Chimpharm's total workforce has grown from 447 employees in 2023 to 536 in 2026.
Chimpharm JSC quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 536 | +30 | +1.6% |
| 2025 | Q4 | 533 | +29 | +2.9% |
| 2025 | Q3 | 552 | +75 | +9.1% |
| 2025 | Q2 | 552 | +91 | +11.4% |
| 2025 | Q1 | 506 | +39 | +8.0% |
| 2024 | Q4 | 504 | +32 | +5.7% |
| 2024 | Q3 | 477 | +31 | +6.3% |
| 2024 | Q2 | 461 | +14 | +1.2% |
| 2024 | Q1 | 467 | +24 | +1.9% |
| 2023 | Q4 | 472 | +37 | +2.4% |
| 2023 | Q3 | 446 | +6 | +0.3% |
| 2023 | Q2 | 447 | +44 | +6.9% |
See Chimpharm's complete headcount history, including quarterly breakdowns.
Get the DataChimpharm Employee Count by Region (2026)
Central and Western Asia accounts for the largest share of Chimpharm's global workforce with approximately 99% of total employees, followed by Southern Europe.
Chimpharm employees by region
| Region | Employees | % of Total |
|---|---|---|
| Central and Western Asia | 518 | 99.0% |
| Southern Europe | 5 | 1.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataChimpharm Employee Count by Department (2026)
Chimpharm's employee groups are Finance and Operations (50.8%), Engineering (33.4%), and Sales and Marketing (15.8%).
Chimpharm employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 272 | 50.8% |
| Engineering | 179 | 33.4% |
| Sales and Marketing | 85 | 15.8% |
Compare Chimpharm's department mix to industry peers.
See Full DataChimpharm Employee Salary by Region (2026)
Chimpharm's average employee salary is $21,680 globally. Employees in Central and Western Asia receive the highest compensation.
Chimpharm median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Central and Western Asia | $13,000 |
Unlock salary by role, level, and city — and compare to Chimpharm's industry peers.
Unlock Salary DataChimpharm Job Openings and Hiring Trends (2023-2026)
- Chimpharm had 8 active job postings in 2026, a 13.3% increase (-3) from 2025.
- Chimpharm had 11 active job postings in 2025, a 44.4% increase (+4) from 2024.
- Chimpharm had 7 active job postings in 2024, a 15.4% increase (+1) from 2023.
- Chimpharm had 6 active job postings in 2023, a 142.9% increase from 2022.
- Hiring velocity in 2026: 4 new roles/month, down from 7 in 2025 and 7 in 2024.
Chimpharm's hiring is accelerating: active job postings rose 13.3% in 2026 to 8, with new postings per month climbing from 2 in 2023 to 4 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataChimpharm Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Chimpharm's workforce based on public professional data. Overall sentiment is negative and has held steady year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Chimpharm
- How fast is Chimpharm growing?
- In 2026, Chimpharm's headcount grew 1.6% to 536 employees, up from 506 in 2025.
- See the full headcount history
- Where are Chimpharm employees located?
- Most Chimpharm employees are based in Central and Western Asia (99.0% of headcount), followed by Southern Europe.
- Explore where the workforce is based
- What is the average salary at Chimpharm?
- The average employee salary at Chimpharm is approximately $21.7k per year.
- Analyze the salary distribution
- How many new job postings does Chimpharm open per year?
- In Q1 2026, Chimpharm opened 13 new job postings. In 2025, Chimpharm opened 78 new job postings — about 7 per month.
- Track hiring trends by role
- When was Chimpharm founded and where is it headquartered?
- Chimpharm was founded in 1882 and is headquartered in Kazakhstan.
- Compare Chimpharm to industry peers
Speak with a workforce expert about Chimpharm.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.